InflaRx NV 주식 가격. IFRX - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

2.44

매수가

2.44

매도가

2.46

거래량

112,366

2.34 일간 변동폭 2.47

1.165 52주 범위 2.815

market_cap

143.675M

전일 종가

2.37

개장가

2.42

최근 거래 시간

100

2.44

마지막 거래 시간

03:13:09

재정 규모

US$ 271,703

VWAP

2.418

평균 볼륨(3m)

317,121

발행 주식

58,883,272

배당수익률

주가수익률

-3.38

주당순이익(EPS)

-0.72

매출

63k

순이익

-42.67M

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator in... InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.inflarx.de

본부

Jena, Deu

설립됨

InflaRx NV is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker IFRX. The last closing price for InflaRx NV was US$2.37. Over the last year, InflaRx NV shares have traded in a share price range of US$ 1.165 to US$ 2.815.

InflaRx NV currently has 58,883,272 shares in issue. The market capitalisation of InflaRx NV is US$139.55 million. InflaRx NV has a price to earnings ratio (PE ratio) of -3.38.

InflaRx Announces Participation in Guggenheim SMID Cap Biotech Conference

JENA, Germany, Jan. 23, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS)

JENA, Germany, Jan. 15, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...

InflaRx Announces Participation in January Events in San Francisco

JENA, Germany, Jan. 07, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904

JENA, Germany, Dec. 20, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome

JENA, Germany, Nov. 15, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update

Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG) to enable interim analysis, with guidance for trial size adaptation or futility expected by the...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.02	0.826446280992	2.42	2.47	2.16	197178	2.30414862	CS
4	-0.06	-2.4	2.5	2.65	2.16	195137	2.39621952	CS
12	0.93	61.5894039735	1.51	2.815	1.5	317121	2.26655893	CS
26	0.89	57.4193548387	1.55	2.815	1.23	177511	2.09346755	CS
52	0.79	47.8787878788	1.65	2.815	1.165	180848	1.80979995	CS
156	-1.03	-29.6829971182	3.47	6.15	0.7762	291562	2.75627874	CS
260	-0.9	-26.9461077844	3.34	9.7	0.7762	519138	3.98131065	CS

IFRX - Frequently Asked Questions (FAQ)

What is the current InflaRx NV share price?

The current share price of InflaRx NV is US$ 2.44

How many InflaRx NV shares are in issue?

InflaRx NV has 58,883,272 shares in issue

What is the market cap of InflaRx NV?

The market capitalisation of InflaRx NV is USD 139.55M

What is the 1 year trading range for InflaRx NV share price?

InflaRx NV has traded in the range of US$ 1.165 to US$ 2.815 during the past year

What is the PE ratio of InflaRx NV?

The price to earnings ratio of InflaRx NV is -3.38

What is the cash to sales ratio of InflaRx NV?

The cash to sales ratio of InflaRx NV is 2.23k

What is the reporting currency for InflaRx NV?

InflaRx NV reports financial results in EUR

What is the latest annual turnover for InflaRx NV?

The latest annual turnover of InflaRx NV is EUR 63k

What is the latest annual profit for InflaRx NV?

The latest annual profit of InflaRx NV is EUR -42.67M

What is the registered address of InflaRx NV?

The registered address for InflaRx NV is WINZERLAER, JENA, 07745

What is the InflaRx NV website address?

The website address for InflaRx NV is www.inflarx.de

Which industry sector does InflaRx NV operate in?

InflaRx NV operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
TCTMTCTM Kids IT Education Inc	US$ 0.82 (352.79%)	625.08M
REBNReborn Coffee Inc	US$ 3.762 (85.32%)	43.87M
CYCNCyclerion Therapeutics Inc	US$ 3.795 (49.41%)	71.89M
SOPASociety Pass Inc	US$ 1.3599 (38.20%)	7.64M
NXUNXU Inc	US$ 0.3092 (29.70%)	134.11M
ENVBEnveric Biosciences Inc	US$ 2.175 (-44.23%)	1.21M
BHILBenson Hill Inc	US$ 2.36 (-40.25%)	2.09M
NIVFNewGenIvf Group Ltd	US$ 0.157901 (-39.03%)	11.53M
SHOTWSafety Shot Inc	US$ 0.1029 (-30.89%)	403
SPGCSacks Parente Golf Inc	US$ 0.6762 (-24.98%)	4.82M
TCTMTCTM Kids IT Education Inc	US$ 0.8191 (352.29%)	625.08M
RIMEAlgorhythm Holdings Inc	US$ 0.0291 (19.26%)	262.84M
NVDANVIDIA Corporation	US$ 125.4731 (0.66%)	203.7M
CLEUChina Liberal Education Holdings Ltd	US$ 0.162 (9.31%)	136M
NXUNXU Inc	US$ 0.313 (31.29%)	134.11M